CT-101 (Cetya Therapeutics)

N/A

Report date: 2023/04/23 16:11:11
NME

Base Information

Drug NameCT-101 (Cetya Therapeutics)
Drug Alias NameCT-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCetya Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCetya Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A